This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

stereotactic ablative radiotherapy (SABR)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Stereotactic radiotherapy (SBRT) gives radiotherapy from many different positions around the body
    • the beams meet at the tumour
      • the tumour receives a high dose of radiation and the tissues around it only receive a low dose
    • also termed stereotactic ablative radiotherapy (SABR)
      • characterized by high doses of radiation per fraction (5-34 Gy), few overall treatment fractions and an accurate tumour targeting system
        • doses delivered in SABR are in contrast to those given in conventionally fractionated radiotherapy, which are typically in the range of 1.8-2 Gy per fraction daily, delivered over several weeks
        • SABR has become widely available due to the advancement of technology in both imaging target tumours and in the precise delivery of radiation

    • lowers the risk of side effects
    • usually you have between 1 to 8 treatments
      • SBRT may be used to treat brain tumours and is called cranial stereotactic radiotherapy

    • this type of radiotherapy is mainly used to treat very small cancers, including:
      • lung cancer
      • liver cancer or liver metastases
      • cancers in the lymph nodes
      • spinal cord tumours

Reference:

  • Lax I, Blomgren H, Näslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-83
  • Bezjak A. RTOG 0813: Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically In-operable Patients.
  • Meyer J, Wilbert J, Baier K, et al. Positioning accuracy of conebeam computed tomography in combination with a HexaPOD robot treatment table. Int J Radiat Oncol Biol Phys 2007;67:1220-8.
  • Li Q, Mu J, Gu W, et al. Frameless stereotactic body radiation therapy for multiple lung metastases. J Appl Clin Med Phys 2014;15:4737.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.